Efficacy of nasogastric and endotracheal tube securement devices, preventative dressings and topical skin applications for reducing device-related pressure injuries in intensive care patients; a pilot study

Not Applicable

Completed

• Conditions: Critical illness; Pressure injuries; Skin - Other skin conditions

• Registration Number: ACTRN12616001174471
• Lead Sponsor: Queensland University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-08-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All ICU patients = or >18 years who have a NGT and/or ETT in situ
Patients who are expected to remain in ICU > 24 hours
NGT or ETT inserted a maximum of 12 hours prior to ICU admission
Patients readmitted to ICU with no oral or nasal skin injury present
NGT arm only - must have wide bore NGT and an ETT in situ.

Exclusion Criteria

Burn patients with an ETT wired in place (ETT arm only)
Patients with NGT sutured in place or nasal bridle (NGT arm only)
Patients with facial trauma
Traumatic brain injured patients requiring intracranial pressure monitoring and/or ventricular drainage of cerebrospinal fluid
Cervical spine injured patients who have a hard collar in situ
Hirsute patients with beards where patient permission to shave is not possible
Patients who are receiving non-invasive ventilation
Patients with a device (NGT or ETT) predicted to be in situ < 48 hours.
Patients with a community or hospital-acquired NGT or ETT PI diagnosed within 24 hours of admission to the ICU.
Patients on whom treatment is withdrawn or who are being palliated.
Patients currently enrolled on three studies in the ICU.

Study & Design

• Study Type: Interventional
• Study Design: Not specified